Global Ophthalmic Drugs Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Ophthalmic Drugs market size was valued at US$ 33070 million in 2023. With growing demand in downstream market, the Ophthalmic Drugs is forecast to a readjusted size of US$ 57020 million by 2030 with a CAGR of 8.1% during review period.
The research report highlights the growth potential of the global Ophthalmic Drugs market. Ophthalmic Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Ophthalmic Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Ophthalmic Drugs market.
Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Ophthalmic Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Ophthalmic Drugs market. It may include historical data, market segmentation by Type (e.g., Anti-allergy, Anti-VEGF Agents), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Ophthalmic Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Ophthalmic Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Ophthalmic Drugs industry. This include advancements in Ophthalmic Drugs technology, Ophthalmic Drugs new entrants, Ophthalmic Drugs new investment, and other innovations that are shaping the future of Ophthalmic Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Ophthalmic Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Ophthalmic Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Ophthalmic Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Ophthalmic Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Ophthalmic Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Ophthalmic Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Ophthalmic Drugs market.
Market Segmentation:
Ophthalmic Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Ophthalmic Drugs market?
What factors are driving Ophthalmic Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ophthalmic Drugs market opportunities vary by end market size?
How does Ophthalmic Drugs break out type, application?
According to our LPI (LP Information) latest study, the global Ophthalmic Drugs market size was valued at US$ 33070 million in 2023. With growing demand in downstream market, the Ophthalmic Drugs is forecast to a readjusted size of US$ 57020 million by 2030 with a CAGR of 8.1% during review period.
The research report highlights the growth potential of the global Ophthalmic Drugs market. Ophthalmic Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Ophthalmic Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Ophthalmic Drugs market.
Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Ophthalmic Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Ophthalmic Drugs market. It may include historical data, market segmentation by Type (e.g., Anti-allergy, Anti-VEGF Agents), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Ophthalmic Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Ophthalmic Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Ophthalmic Drugs industry. This include advancements in Ophthalmic Drugs technology, Ophthalmic Drugs new entrants, Ophthalmic Drugs new investment, and other innovations that are shaping the future of Ophthalmic Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Ophthalmic Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Ophthalmic Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Ophthalmic Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Ophthalmic Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Ophthalmic Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Ophthalmic Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Ophthalmic Drugs market.
Market Segmentation:
Ophthalmic Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Anti-allergy
- Anti-VEGF Agents
- Anti-inflammatory
- Anti-glaucoma
- Hospital
- Clinic
- Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Santen Pharmaceutical
- Bausch Health
- Takeda
- Novartis
- Genentech
- Allergan
- Sun Pharmaceutical Industries
- Actavis Generics
- Regeneron Pharmaceuticals
- Pfizer
- Johnson and Johnson
- Bausch and Lomb
What is the 10-year outlook for the global Ophthalmic Drugs market?
What factors are driving Ophthalmic Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ophthalmic Drugs market opportunities vary by end market size?
How does Ophthalmic Drugs break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ophthalmic Drugs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Ophthalmic Drugs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Ophthalmic Drugs by Country/Region, 2019, 2023 & 2030
2.2 Ophthalmic Drugs Segment by Type
2.2.1 Anti-allergy
2.2.2 Anti-VEGF Agents
2.2.3 Anti-inflammatory
2.2.4 Anti-glaucoma
2.3 Ophthalmic Drugs Sales by Type
2.3.1 Global Ophthalmic Drugs Sales Market Share by Type (2019-2024)
2.3.2 Global Ophthalmic Drugs Revenue and Market Share by Type (2019-2024)
2.3.3 Global Ophthalmic Drugs Sale Price by Type (2019-2024)
2.4 Ophthalmic Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Pharmacy
2.5 Ophthalmic Drugs Sales by Application
2.5.1 Global Ophthalmic Drugs Sale Market Share by Application (2019-2024)
2.5.2 Global Ophthalmic Drugs Revenue and Market Share by Application (2019-2024)
2.5.3 Global Ophthalmic Drugs Sale Price by Application (2019-2024)
3 GLOBAL OPHTHALMIC DRUGS BY COMPANY
3.1 Global Ophthalmic Drugs Breakdown Data by Company
3.1.1 Global Ophthalmic Drugs Annual Sales by Company (2019-2024)
3.1.2 Global Ophthalmic Drugs Sales Market Share by Company (2019-2024)
3.2 Global Ophthalmic Drugs Annual Revenue by Company (2019-2024)
3.2.1 Global Ophthalmic Drugs Revenue by Company (2019-2024)
3.2.2 Global Ophthalmic Drugs Revenue Market Share by Company (2019-2024)
3.3 Global Ophthalmic Drugs Sale Price by Company
3.4 Key Manufacturers Ophthalmic Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ophthalmic Drugs Product Location Distribution
3.4.2 Players Ophthalmic Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OPHTHALMIC DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Ophthalmic Drugs Market Size by Geographic Region (2019-2024)
4.1.1 Global Ophthalmic Drugs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Ophthalmic Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Ophthalmic Drugs Market Size by Country/Region (2019-2024)
4.2.1 Global Ophthalmic Drugs Annual Sales by Country/Region (2019-2024)
4.2.2 Global Ophthalmic Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Ophthalmic Drugs Sales Growth
4.4 APAC Ophthalmic Drugs Sales Growth
4.5 Europe Ophthalmic Drugs Sales Growth
4.6 Middle East & Africa Ophthalmic Drugs Sales Growth
5 AMERICAS
5.1 Americas Ophthalmic Drugs Sales by Country
5.1.1 Americas Ophthalmic Drugs Sales by Country (2019-2024)
5.1.2 Americas Ophthalmic Drugs Revenue by Country (2019-2024)
5.2 Americas Ophthalmic Drugs Sales by Type
5.3 Americas Ophthalmic Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ophthalmic Drugs Sales by Region
6.1.1 APAC Ophthalmic Drugs Sales by Region (2019-2024)
6.1.2 APAC Ophthalmic Drugs Revenue by Region (2019-2024)
6.2 APAC Ophthalmic Drugs Sales by Type
6.3 APAC Ophthalmic Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Ophthalmic Drugs by Country
7.1.1 Europe Ophthalmic Drugs Sales by Country (2019-2024)
7.1.2 Europe Ophthalmic Drugs Revenue by Country (2019-2024)
7.2 Europe Ophthalmic Drugs Sales by Type
7.3 Europe Ophthalmic Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ophthalmic Drugs by Country
8.1.1 Middle East & Africa Ophthalmic Drugs Sales by Country (2019-2024)
8.1.2 Middle East & Africa Ophthalmic Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa Ophthalmic Drugs Sales by Type
8.3 Middle East & Africa Ophthalmic Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ophthalmic Drugs
10.3 Manufacturing Process Analysis of Ophthalmic Drugs
10.4 Industry Chain Structure of Ophthalmic Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ophthalmic Drugs Distributors
11.3 Ophthalmic Drugs Customer
12 WORLD FORECAST REVIEW FOR OPHTHALMIC DRUGS BY GEOGRAPHIC REGION
12.1 Global Ophthalmic Drugs Market Size Forecast by Region
12.1.1 Global Ophthalmic Drugs Forecast by Region (2025-2030)
12.1.2 Global Ophthalmic Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ophthalmic Drugs Forecast by Type
12.7 Global Ophthalmic Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Santen Pharmaceutical
13.1.1 Santen Pharmaceutical Company Information
13.1.2 Santen Pharmaceutical Ophthalmic Drugs Product Portfolios and Specifications
13.1.3 Santen Pharmaceutical Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Santen Pharmaceutical Main Business Overview
13.1.5 Santen Pharmaceutical Latest Developments
13.2 Bausch Health
13.2.1 Bausch Health Company Information
13.2.2 Bausch Health Ophthalmic Drugs Product Portfolios and Specifications
13.2.3 Bausch Health Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bausch Health Main Business Overview
13.2.5 Bausch Health Latest Developments
13.3 Takeda
13.3.1 Takeda Company Information
13.3.2 Takeda Ophthalmic Drugs Product Portfolios and Specifications
13.3.3 Takeda Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Takeda Main Business Overview
13.3.5 Takeda Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Ophthalmic Drugs Product Portfolios and Specifications
13.4.3 Novartis Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Genentech
13.5.1 Genentech Company Information
13.5.2 Genentech Ophthalmic Drugs Product Portfolios and Specifications
13.5.3 Genentech Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Genentech Main Business Overview
13.5.5 Genentech Latest Developments
13.6 Allergan
13.6.1 Allergan Company Information
13.6.2 Allergan Ophthalmic Drugs Product Portfolios and Specifications
13.6.3 Allergan Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Allergan Main Business Overview
13.6.5 Allergan Latest Developments
13.7 Sun Pharmaceutical Industries
13.7.1 Sun Pharmaceutical Industries Company Information
13.7.2 Sun Pharmaceutical Industries Ophthalmic Drugs Product Portfolios and Specifications
13.7.3 Sun Pharmaceutical Industries Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sun Pharmaceutical Industries Main Business Overview
13.7.5 Sun Pharmaceutical Industries Latest Developments
13.8 Actavis Generics
13.8.1 Actavis Generics Company Information
13.8.2 Actavis Generics Ophthalmic Drugs Product Portfolios and Specifications
13.8.3 Actavis Generics Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Actavis Generics Main Business Overview
13.8.5 Actavis Generics Latest Developments
13.9 Regeneron Pharmaceuticals
13.9.1 Regeneron Pharmaceuticals Company Information
13.9.2 Regeneron Pharmaceuticals Ophthalmic Drugs Product Portfolios and Specifications
13.9.3 Regeneron Pharmaceuticals Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Regeneron Pharmaceuticals Main Business Overview
13.9.5 Regeneron Pharmaceuticals Latest Developments
13.10 Pfizer
13.10.1 Pfizer Company Information
13.10.2 Pfizer Ophthalmic Drugs Product Portfolios and Specifications
13.10.3 Pfizer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Pfizer Main Business Overview
13.10.5 Pfizer Latest Developments
13.11 Johnson and Johnson
13.11.1 Johnson and Johnson Company Information
13.11.2 Johnson and Johnson Ophthalmic Drugs Product Portfolios and Specifications
13.11.3 Johnson and Johnson Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Johnson and Johnson Main Business Overview
13.11.5 Johnson and Johnson Latest Developments
13.12 Bausch and Lomb
13.12.1 Bausch and Lomb Company Information
13.12.2 Bausch and Lomb Ophthalmic Drugs Product Portfolios and Specifications
13.12.3 Bausch and Lomb Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Bausch and Lomb Main Business Overview
13.12.5 Bausch and Lomb Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ophthalmic Drugs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Ophthalmic Drugs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Ophthalmic Drugs by Country/Region, 2019, 2023 & 2030
2.2 Ophthalmic Drugs Segment by Type
2.2.1 Anti-allergy
2.2.2 Anti-VEGF Agents
2.2.3 Anti-inflammatory
2.2.4 Anti-glaucoma
2.3 Ophthalmic Drugs Sales by Type
2.3.1 Global Ophthalmic Drugs Sales Market Share by Type (2019-2024)
2.3.2 Global Ophthalmic Drugs Revenue and Market Share by Type (2019-2024)
2.3.3 Global Ophthalmic Drugs Sale Price by Type (2019-2024)
2.4 Ophthalmic Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Pharmacy
2.5 Ophthalmic Drugs Sales by Application
2.5.1 Global Ophthalmic Drugs Sale Market Share by Application (2019-2024)
2.5.2 Global Ophthalmic Drugs Revenue and Market Share by Application (2019-2024)
2.5.3 Global Ophthalmic Drugs Sale Price by Application (2019-2024)
3 GLOBAL OPHTHALMIC DRUGS BY COMPANY
3.1 Global Ophthalmic Drugs Breakdown Data by Company
3.1.1 Global Ophthalmic Drugs Annual Sales by Company (2019-2024)
3.1.2 Global Ophthalmic Drugs Sales Market Share by Company (2019-2024)
3.2 Global Ophthalmic Drugs Annual Revenue by Company (2019-2024)
3.2.1 Global Ophthalmic Drugs Revenue by Company (2019-2024)
3.2.2 Global Ophthalmic Drugs Revenue Market Share by Company (2019-2024)
3.3 Global Ophthalmic Drugs Sale Price by Company
3.4 Key Manufacturers Ophthalmic Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ophthalmic Drugs Product Location Distribution
3.4.2 Players Ophthalmic Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OPHTHALMIC DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Ophthalmic Drugs Market Size by Geographic Region (2019-2024)
4.1.1 Global Ophthalmic Drugs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Ophthalmic Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Ophthalmic Drugs Market Size by Country/Region (2019-2024)
4.2.1 Global Ophthalmic Drugs Annual Sales by Country/Region (2019-2024)
4.2.2 Global Ophthalmic Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Ophthalmic Drugs Sales Growth
4.4 APAC Ophthalmic Drugs Sales Growth
4.5 Europe Ophthalmic Drugs Sales Growth
4.6 Middle East & Africa Ophthalmic Drugs Sales Growth
5 AMERICAS
5.1 Americas Ophthalmic Drugs Sales by Country
5.1.1 Americas Ophthalmic Drugs Sales by Country (2019-2024)
5.1.2 Americas Ophthalmic Drugs Revenue by Country (2019-2024)
5.2 Americas Ophthalmic Drugs Sales by Type
5.3 Americas Ophthalmic Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ophthalmic Drugs Sales by Region
6.1.1 APAC Ophthalmic Drugs Sales by Region (2019-2024)
6.1.2 APAC Ophthalmic Drugs Revenue by Region (2019-2024)
6.2 APAC Ophthalmic Drugs Sales by Type
6.3 APAC Ophthalmic Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Ophthalmic Drugs by Country
7.1.1 Europe Ophthalmic Drugs Sales by Country (2019-2024)
7.1.2 Europe Ophthalmic Drugs Revenue by Country (2019-2024)
7.2 Europe Ophthalmic Drugs Sales by Type
7.3 Europe Ophthalmic Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ophthalmic Drugs by Country
8.1.1 Middle East & Africa Ophthalmic Drugs Sales by Country (2019-2024)
8.1.2 Middle East & Africa Ophthalmic Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa Ophthalmic Drugs Sales by Type
8.3 Middle East & Africa Ophthalmic Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ophthalmic Drugs
10.3 Manufacturing Process Analysis of Ophthalmic Drugs
10.4 Industry Chain Structure of Ophthalmic Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ophthalmic Drugs Distributors
11.3 Ophthalmic Drugs Customer
12 WORLD FORECAST REVIEW FOR OPHTHALMIC DRUGS BY GEOGRAPHIC REGION
12.1 Global Ophthalmic Drugs Market Size Forecast by Region
12.1.1 Global Ophthalmic Drugs Forecast by Region (2025-2030)
12.1.2 Global Ophthalmic Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ophthalmic Drugs Forecast by Type
12.7 Global Ophthalmic Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Santen Pharmaceutical
13.1.1 Santen Pharmaceutical Company Information
13.1.2 Santen Pharmaceutical Ophthalmic Drugs Product Portfolios and Specifications
13.1.3 Santen Pharmaceutical Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Santen Pharmaceutical Main Business Overview
13.1.5 Santen Pharmaceutical Latest Developments
13.2 Bausch Health
13.2.1 Bausch Health Company Information
13.2.2 Bausch Health Ophthalmic Drugs Product Portfolios and Specifications
13.2.3 Bausch Health Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bausch Health Main Business Overview
13.2.5 Bausch Health Latest Developments
13.3 Takeda
13.3.1 Takeda Company Information
13.3.2 Takeda Ophthalmic Drugs Product Portfolios and Specifications
13.3.3 Takeda Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Takeda Main Business Overview
13.3.5 Takeda Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Ophthalmic Drugs Product Portfolios and Specifications
13.4.3 Novartis Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Genentech
13.5.1 Genentech Company Information
13.5.2 Genentech Ophthalmic Drugs Product Portfolios and Specifications
13.5.3 Genentech Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Genentech Main Business Overview
13.5.5 Genentech Latest Developments
13.6 Allergan
13.6.1 Allergan Company Information
13.6.2 Allergan Ophthalmic Drugs Product Portfolios and Specifications
13.6.3 Allergan Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Allergan Main Business Overview
13.6.5 Allergan Latest Developments
13.7 Sun Pharmaceutical Industries
13.7.1 Sun Pharmaceutical Industries Company Information
13.7.2 Sun Pharmaceutical Industries Ophthalmic Drugs Product Portfolios and Specifications
13.7.3 Sun Pharmaceutical Industries Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sun Pharmaceutical Industries Main Business Overview
13.7.5 Sun Pharmaceutical Industries Latest Developments
13.8 Actavis Generics
13.8.1 Actavis Generics Company Information
13.8.2 Actavis Generics Ophthalmic Drugs Product Portfolios and Specifications
13.8.3 Actavis Generics Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Actavis Generics Main Business Overview
13.8.5 Actavis Generics Latest Developments
13.9 Regeneron Pharmaceuticals
13.9.1 Regeneron Pharmaceuticals Company Information
13.9.2 Regeneron Pharmaceuticals Ophthalmic Drugs Product Portfolios and Specifications
13.9.3 Regeneron Pharmaceuticals Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Regeneron Pharmaceuticals Main Business Overview
13.9.5 Regeneron Pharmaceuticals Latest Developments
13.10 Pfizer
13.10.1 Pfizer Company Information
13.10.2 Pfizer Ophthalmic Drugs Product Portfolios and Specifications
13.10.3 Pfizer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Pfizer Main Business Overview
13.10.5 Pfizer Latest Developments
13.11 Johnson and Johnson
13.11.1 Johnson and Johnson Company Information
13.11.2 Johnson and Johnson Ophthalmic Drugs Product Portfolios and Specifications
13.11.3 Johnson and Johnson Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Johnson and Johnson Main Business Overview
13.11.5 Johnson and Johnson Latest Developments
13.12 Bausch and Lomb
13.12.1 Bausch and Lomb Company Information
13.12.2 Bausch and Lomb Ophthalmic Drugs Product Portfolios and Specifications
13.12.3 Bausch and Lomb Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Bausch and Lomb Main Business Overview
13.12.5 Bausch and Lomb Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Ophthalmic Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Ophthalmic Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Anti-allergy
Table 4. Major Players of Anti-VEGF Agents
Table 5. Major Players of Anti-inflammatory
Table 6. Major Players of Anti-glaucoma
Table 7. Global Ophthalmic Drugs Sales by Type (2019-2024) & (K MT)
Table 8. Global Ophthalmic Drugs Sales Market Share by Type (2019-2024)
Table 9. Global Ophthalmic Drugs Revenue by Type (2019-2024) & ($ million)
Table 10. Global Ophthalmic Drugs Revenue Market Share by Type (2019-2024)
Table 11. Global Ophthalmic Drugs Sale Price by Type (2019-2024) & (USD/MT)
Table 12. Global Ophthalmic Drugs Sales by Application (2019-2024) & (K MT)
Table 13. Global Ophthalmic Drugs Sales Market Share by Application (2019-2024)
Table 14. Global Ophthalmic Drugs Revenue by Application (2019-2024)
Table 15. Global Ophthalmic Drugs Revenue Market Share by Application (2019-2024)
Table 16. Global Ophthalmic Drugs Sale Price by Application (2019-2024) & (USD/MT)
Table 17. Global Ophthalmic Drugs Sales by Company (2019-2024) & (K MT)
Table 18. Global Ophthalmic Drugs Sales Market Share by Company (2019-2024)
Table 19. Global Ophthalmic Drugs Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Ophthalmic Drugs Revenue Market Share by Company (2019-2024)
Table 21. Global Ophthalmic Drugs Sale Price by Company (2019-2024) & (USD/MT)
Table 22. Key Manufacturers Ophthalmic Drugs Producing Area Distribution and Sales Area
Table 23. Players Ophthalmic Drugs Products Offered
Table 24. Ophthalmic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Ophthalmic Drugs Sales by Geographic Region (2019-2024) & (K MT)
Table 28. Global Ophthalmic Drugs Sales Market Share Geographic Region (2019-2024)
Table 29. Global Ophthalmic Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Ophthalmic Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Ophthalmic Drugs Sales by Country/Region (2019-2024) & (K MT)
Table 32. Global Ophthalmic Drugs Sales Market Share by Country/Region (2019-2024)
Table 33. Global Ophthalmic Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Ophthalmic Drugs Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Ophthalmic Drugs Sales by Country (2019-2024) & (K MT)
Table 36. Americas Ophthalmic Drugs Sales Market Share by Country (2019-2024)
Table 37. Americas Ophthalmic Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Ophthalmic Drugs Revenue Market Share by Country (2019-2024)
Table 39. Americas Ophthalmic Drugs Sales by Type (2019-2024) & (K MT)
Table 40. Americas Ophthalmic Drugs Sales by Application (2019-2024) & (K MT)
Table 41. APAC Ophthalmic Drugs Sales by Region (2019-2024) & (K MT)
Table 42. APAC Ophthalmic Drugs Sales Market Share by Region (2019-2024)
Table 43. APAC Ophthalmic Drugs Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Ophthalmic Drugs Revenue Market Share by Region (2019-2024)
Table 45. APAC Ophthalmic Drugs Sales by Type (2019-2024) & (K MT)
Table 46. APAC Ophthalmic Drugs Sales by Application (2019-2024) & (K MT)
Table 47. Europe Ophthalmic Drugs Sales by Country (2019-2024) & (K MT)
Table 48. Europe Ophthalmic Drugs Sales Market Share by Country (2019-2024)
Table 49. Europe Ophthalmic Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Ophthalmic Drugs Revenue Market Share by Country (2019-2024)
Table 51. Europe Ophthalmic Drugs Sales by Type (2019-2024) & (K MT)
Table 52. Europe Ophthalmic Drugs Sales by Application (2019-2024) & (K MT)
Table 53. Middle East & Africa Ophthalmic Drugs Sales by Country (2019-2024) & (K MT)
Table 54. Middle East & Africa Ophthalmic Drugs Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Ophthalmic Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Ophthalmic Drugs Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Ophthalmic Drugs Sales by Type (2019-2024) & (K MT)
Table 58. Middle East & Africa Ophthalmic Drugs Sales by Application (2019-2024) & (K MT)
Table 59. Key Market Drivers & Growth Opportunities of Ophthalmic Drugs
Table 60. Key Market Challenges & Risks of Ophthalmic Drugs
Table 61. Key Industry Trends of Ophthalmic Drugs
Table 62. Ophthalmic Drugs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Ophthalmic Drugs Distributors List
Table 65. Ophthalmic Drugs Customer List
Table 66. Global Ophthalmic Drugs Sales Forecast by Region (2025-2030) & (K MT)
Table 67. Global Ophthalmic Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Ophthalmic Drugs Sales Forecast by Country (2025-2030) & (K MT)
Table 69. Americas Ophthalmic Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Ophthalmic Drugs Sales Forecast by Region (2025-2030) & (K MT)
Table 71. APAC Ophthalmic Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Ophthalmic Drugs Sales Forecast by Country (2025-2030) & (K MT)
Table 73. Europe Ophthalmic Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Ophthalmic Drugs Sales Forecast by Country (2025-2030) & (K MT)
Table 75. Middle East & Africa Ophthalmic Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Ophthalmic Drugs Sales Forecast by Type (2025-2030) & (K MT)
Table 77. Global Ophthalmic Drugs Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Ophthalmic Drugs Sales Forecast by Application (2025-2030) & (K MT)
Table 79. Global Ophthalmic Drugs Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Santen Pharmaceutical Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Santen Pharmaceutical Ophthalmic Drugs Product Portfolios and Specifications
Table 82. Santen Pharmaceutical Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Santen Pharmaceutical Main Business
Table 84. Santen Pharmaceutical Latest Developments
Table 85. Bausch Health Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Bausch Health Ophthalmic Drugs Product Portfolios and Specifications
Table 87. Bausch Health Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. Bausch Health Main Business
Table 89. Bausch Health Latest Developments
Table 90. Takeda Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Takeda Ophthalmic Drugs Product Portfolios and Specifications
Table 92. Takeda Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. Takeda Main Business
Table 94. Takeda Latest Developments
Table 95. Novartis Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Novartis Ophthalmic Drugs Product Portfolios and Specifications
Table 97. Novartis Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 98. Novartis Main Business
Table 99. Novartis Latest Developments
Table 100. Genentech Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Genentech Ophthalmic Drugs Product Portfolios and Specifications
Table 102. Genentech Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 103. Genentech Main Business
Table 104. Genentech Latest Developments
Table 105. Allergan Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Allergan Ophthalmic Drugs Product Portfolios and Specifications
Table 107. Allergan Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 108. Allergan Main Business
Table 109. Allergan Latest Developments
Table 110. Sun Pharmaceutical Industries Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Sun Pharmaceutical Industries Ophthalmic Drugs Product Portfolios and Specifications
Table 112. Sun Pharmaceutical Industries Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 113. Sun Pharmaceutical Industries Main Business
Table 114. Sun Pharmaceutical Industries Latest Developments
Table 115. Actavis Generics Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Actavis Generics Ophthalmic Drugs Product Portfolios and Specifications
Table 117. Actavis Generics Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 118. Actavis Generics Main Business
Table 119. Actavis Generics Latest Developments
Table 120. Regeneron Pharmaceuticals Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Regeneron Pharmaceuticals Ophthalmic Drugs Product Portfolios and Specifications
Table 122. Regeneron Pharmaceuticals Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 123. Regeneron Pharmaceuticals Main Business
Table 124. Regeneron Pharmaceuticals Latest Developments
Table 125. Pfizer Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Pfizer Ophthalmic Drugs Product Portfolios and Specifications
Table 127. Pfizer Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 128. Pfizer Main Business
Table 129. Pfizer Latest Developments
Table 130. Johnson and Johnson Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Johnson and Johnson Ophthalmic Drugs Product Portfolios and Specifications
Table 132. Johnson and Johnson Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 133. Johnson and Johnson Main Business
Table 134. Johnson and Johnson Latest Developments
Table 135. Bausch and Lomb Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Bausch and Lomb Ophthalmic Drugs Product Portfolios and Specifications
Table 137. Bausch and Lomb Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 138. Bausch and Lomb Main Business
Table 139. Bausch and Lomb Latest Developments
Table 1. Ophthalmic Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Ophthalmic Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Anti-allergy
Table 4. Major Players of Anti-VEGF Agents
Table 5. Major Players of Anti-inflammatory
Table 6. Major Players of Anti-glaucoma
Table 7. Global Ophthalmic Drugs Sales by Type (2019-2024) & (K MT)
Table 8. Global Ophthalmic Drugs Sales Market Share by Type (2019-2024)
Table 9. Global Ophthalmic Drugs Revenue by Type (2019-2024) & ($ million)
Table 10. Global Ophthalmic Drugs Revenue Market Share by Type (2019-2024)
Table 11. Global Ophthalmic Drugs Sale Price by Type (2019-2024) & (USD/MT)
Table 12. Global Ophthalmic Drugs Sales by Application (2019-2024) & (K MT)
Table 13. Global Ophthalmic Drugs Sales Market Share by Application (2019-2024)
Table 14. Global Ophthalmic Drugs Revenue by Application (2019-2024)
Table 15. Global Ophthalmic Drugs Revenue Market Share by Application (2019-2024)
Table 16. Global Ophthalmic Drugs Sale Price by Application (2019-2024) & (USD/MT)
Table 17. Global Ophthalmic Drugs Sales by Company (2019-2024) & (K MT)
Table 18. Global Ophthalmic Drugs Sales Market Share by Company (2019-2024)
Table 19. Global Ophthalmic Drugs Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Ophthalmic Drugs Revenue Market Share by Company (2019-2024)
Table 21. Global Ophthalmic Drugs Sale Price by Company (2019-2024) & (USD/MT)
Table 22. Key Manufacturers Ophthalmic Drugs Producing Area Distribution and Sales Area
Table 23. Players Ophthalmic Drugs Products Offered
Table 24. Ophthalmic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Ophthalmic Drugs Sales by Geographic Region (2019-2024) & (K MT)
Table 28. Global Ophthalmic Drugs Sales Market Share Geographic Region (2019-2024)
Table 29. Global Ophthalmic Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Ophthalmic Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Ophthalmic Drugs Sales by Country/Region (2019-2024) & (K MT)
Table 32. Global Ophthalmic Drugs Sales Market Share by Country/Region (2019-2024)
Table 33. Global Ophthalmic Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Ophthalmic Drugs Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Ophthalmic Drugs Sales by Country (2019-2024) & (K MT)
Table 36. Americas Ophthalmic Drugs Sales Market Share by Country (2019-2024)
Table 37. Americas Ophthalmic Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Ophthalmic Drugs Revenue Market Share by Country (2019-2024)
Table 39. Americas Ophthalmic Drugs Sales by Type (2019-2024) & (K MT)
Table 40. Americas Ophthalmic Drugs Sales by Application (2019-2024) & (K MT)
Table 41. APAC Ophthalmic Drugs Sales by Region (2019-2024) & (K MT)
Table 42. APAC Ophthalmic Drugs Sales Market Share by Region (2019-2024)
Table 43. APAC Ophthalmic Drugs Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Ophthalmic Drugs Revenue Market Share by Region (2019-2024)
Table 45. APAC Ophthalmic Drugs Sales by Type (2019-2024) & (K MT)
Table 46. APAC Ophthalmic Drugs Sales by Application (2019-2024) & (K MT)
Table 47. Europe Ophthalmic Drugs Sales by Country (2019-2024) & (K MT)
Table 48. Europe Ophthalmic Drugs Sales Market Share by Country (2019-2024)
Table 49. Europe Ophthalmic Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Ophthalmic Drugs Revenue Market Share by Country (2019-2024)
Table 51. Europe Ophthalmic Drugs Sales by Type (2019-2024) & (K MT)
Table 52. Europe Ophthalmic Drugs Sales by Application (2019-2024) & (K MT)
Table 53. Middle East & Africa Ophthalmic Drugs Sales by Country (2019-2024) & (K MT)
Table 54. Middle East & Africa Ophthalmic Drugs Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Ophthalmic Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Ophthalmic Drugs Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Ophthalmic Drugs Sales by Type (2019-2024) & (K MT)
Table 58. Middle East & Africa Ophthalmic Drugs Sales by Application (2019-2024) & (K MT)
Table 59. Key Market Drivers & Growth Opportunities of Ophthalmic Drugs
Table 60. Key Market Challenges & Risks of Ophthalmic Drugs
Table 61. Key Industry Trends of Ophthalmic Drugs
Table 62. Ophthalmic Drugs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Ophthalmic Drugs Distributors List
Table 65. Ophthalmic Drugs Customer List
Table 66. Global Ophthalmic Drugs Sales Forecast by Region (2025-2030) & (K MT)
Table 67. Global Ophthalmic Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Ophthalmic Drugs Sales Forecast by Country (2025-2030) & (K MT)
Table 69. Americas Ophthalmic Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Ophthalmic Drugs Sales Forecast by Region (2025-2030) & (K MT)
Table 71. APAC Ophthalmic Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Ophthalmic Drugs Sales Forecast by Country (2025-2030) & (K MT)
Table 73. Europe Ophthalmic Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Ophthalmic Drugs Sales Forecast by Country (2025-2030) & (K MT)
Table 75. Middle East & Africa Ophthalmic Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Ophthalmic Drugs Sales Forecast by Type (2025-2030) & (K MT)
Table 77. Global Ophthalmic Drugs Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Ophthalmic Drugs Sales Forecast by Application (2025-2030) & (K MT)
Table 79. Global Ophthalmic Drugs Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Santen Pharmaceutical Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Santen Pharmaceutical Ophthalmic Drugs Product Portfolios and Specifications
Table 82. Santen Pharmaceutical Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Santen Pharmaceutical Main Business
Table 84. Santen Pharmaceutical Latest Developments
Table 85. Bausch Health Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Bausch Health Ophthalmic Drugs Product Portfolios and Specifications
Table 87. Bausch Health Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. Bausch Health Main Business
Table 89. Bausch Health Latest Developments
Table 90. Takeda Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Takeda Ophthalmic Drugs Product Portfolios and Specifications
Table 92. Takeda Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. Takeda Main Business
Table 94. Takeda Latest Developments
Table 95. Novartis Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Novartis Ophthalmic Drugs Product Portfolios and Specifications
Table 97. Novartis Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 98. Novartis Main Business
Table 99. Novartis Latest Developments
Table 100. Genentech Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Genentech Ophthalmic Drugs Product Portfolios and Specifications
Table 102. Genentech Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 103. Genentech Main Business
Table 104. Genentech Latest Developments
Table 105. Allergan Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Allergan Ophthalmic Drugs Product Portfolios and Specifications
Table 107. Allergan Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 108. Allergan Main Business
Table 109. Allergan Latest Developments
Table 110. Sun Pharmaceutical Industries Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Sun Pharmaceutical Industries Ophthalmic Drugs Product Portfolios and Specifications
Table 112. Sun Pharmaceutical Industries Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 113. Sun Pharmaceutical Industries Main Business
Table 114. Sun Pharmaceutical Industries Latest Developments
Table 115. Actavis Generics Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Actavis Generics Ophthalmic Drugs Product Portfolios and Specifications
Table 117. Actavis Generics Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 118. Actavis Generics Main Business
Table 119. Actavis Generics Latest Developments
Table 120. Regeneron Pharmaceuticals Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Regeneron Pharmaceuticals Ophthalmic Drugs Product Portfolios and Specifications
Table 122. Regeneron Pharmaceuticals Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 123. Regeneron Pharmaceuticals Main Business
Table 124. Regeneron Pharmaceuticals Latest Developments
Table 125. Pfizer Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Pfizer Ophthalmic Drugs Product Portfolios and Specifications
Table 127. Pfizer Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 128. Pfizer Main Business
Table 129. Pfizer Latest Developments
Table 130. Johnson and Johnson Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Johnson and Johnson Ophthalmic Drugs Product Portfolios and Specifications
Table 132. Johnson and Johnson Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 133. Johnson and Johnson Main Business
Table 134. Johnson and Johnson Latest Developments
Table 135. Bausch and Lomb Basic Information, Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Bausch and Lomb Ophthalmic Drugs Product Portfolios and Specifications
Table 137. Bausch and Lomb Ophthalmic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 138. Bausch and Lomb Main Business
Table 139. Bausch and Lomb Latest Developments
LIST OF FIGURES
Figure 1. Picture of Ophthalmic Drugs
Figure 2. Ophthalmic Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ophthalmic Drugs Sales Growth Rate 2019-2030 (K MT)
Figure 7. Global Ophthalmic Drugs Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Ophthalmic Drugs Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Anti-allergy
Figure 10. Product Picture of Anti-VEGF Agents
Figure 11. Product Picture of Anti-inflammatory
Figure 12. Product Picture of Anti-glaucoma
Figure 13. Global Ophthalmic Drugs Sales Market Share by Type in 2023
Figure 14. Global Ophthalmic Drugs Revenue Market Share by Type (2019-2024)
Figure 15. Ophthalmic Drugs Consumed in Hospital
Figure 16. Global Ophthalmic Drugs Market: Hospital (2019-2024) & (K MT)
Figure 17. Ophthalmic Drugs Consumed in Clinic
Figure 18. Global Ophthalmic Drugs Market: Clinic (2019-2024) & (K MT)
Figure 19. Ophthalmic Drugs Consumed in Pharmacy
Figure 20. Global Ophthalmic Drugs Market: Pharmacy (2019-2024) & (K MT)
Figure 21. Global Ophthalmic Drugs Sales Market Share by Application (2023)
Figure 22. Global Ophthalmic Drugs Revenue Market Share by Application in 2023
Figure 23. Ophthalmic Drugs Sales Market by Company in 2023 (K MT)
Figure 24. Global Ophthalmic Drugs Sales Market Share by Company in 2023
Figure 25. Ophthalmic Drugs Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Ophthalmic Drugs Revenue Market Share by Company in 2023
Figure 27. Global Ophthalmic Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Ophthalmic Drugs Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Ophthalmic Drugs Sales 2019-2024 (K MT)
Figure 30. Americas Ophthalmic Drugs Revenue 2019-2024 ($ Millions)
Figure 31. APAC Ophthalmic Drugs Sales 2019-2024 (K MT)
Figure 32. APAC Ophthalmic Drugs Revenue 2019-2024 ($ Millions)
Figure 33. Europe Ophthalmic Drugs Sales 2019-2024 (K MT)
Figure 34. Europe Ophthalmic Drugs Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Ophthalmic Drugs Sales 2019-2024 (K MT)
Figure 36. Middle East & Africa Ophthalmic Drugs Revenue 2019-2024 ($ Millions)
Figure 37. Americas Ophthalmic Drugs Sales Market Share by Country in 2023
Figure 38. Americas Ophthalmic Drugs Revenue Market Share by Country in 2023
Figure 39. Americas Ophthalmic Drugs Sales Market Share by Type (2019-2024)
Figure 40. Americas Ophthalmic Drugs Sales Market Share by Application (2019-2024)
Figure 41. United States Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Ophthalmic Drugs Sales Market Share by Region in 2023
Figure 46. APAC Ophthalmic Drugs Revenue Market Share by Regions in 2023
Figure 47. APAC Ophthalmic Drugs Sales Market Share by Type (2019-2024)
Figure 48. APAC Ophthalmic Drugs Sales Market Share by Application (2019-2024)
Figure 49. China Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Ophthalmic Drugs Sales Market Share by Country in 2023
Figure 57. Europe Ophthalmic Drugs Revenue Market Share by Country in 2023
Figure 58. Europe Ophthalmic Drugs Sales Market Share by Type (2019-2024)
Figure 59. Europe Ophthalmic Drugs Sales Market Share by Application (2019-2024)
Figure 60. Germany Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Ophthalmic Drugs Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Ophthalmic Drugs Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Ophthalmic Drugs Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Ophthalmic Drugs Sales Market Share by Application (2019-2024)
Figure 69. Egypt Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Ophthalmic Drugs in 2023
Figure 75. Manufacturing Process Analysis of Ophthalmic Drugs
Figure 76. Industry Chain Structure of Ophthalmic Drugs
Figure 77. Channels of Distribution
Figure 78. Global Ophthalmic Drugs Sales Market Forecast by Region (2025-2030)
Figure 79. Global Ophthalmic Drugs Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Ophthalmic Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Ophthalmic Drugs Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Ophthalmic Drugs Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Ophthalmic Drugs Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Ophthalmic Drugs
Figure 2. Ophthalmic Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ophthalmic Drugs Sales Growth Rate 2019-2030 (K MT)
Figure 7. Global Ophthalmic Drugs Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Ophthalmic Drugs Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Anti-allergy
Figure 10. Product Picture of Anti-VEGF Agents
Figure 11. Product Picture of Anti-inflammatory
Figure 12. Product Picture of Anti-glaucoma
Figure 13. Global Ophthalmic Drugs Sales Market Share by Type in 2023
Figure 14. Global Ophthalmic Drugs Revenue Market Share by Type (2019-2024)
Figure 15. Ophthalmic Drugs Consumed in Hospital
Figure 16. Global Ophthalmic Drugs Market: Hospital (2019-2024) & (K MT)
Figure 17. Ophthalmic Drugs Consumed in Clinic
Figure 18. Global Ophthalmic Drugs Market: Clinic (2019-2024) & (K MT)
Figure 19. Ophthalmic Drugs Consumed in Pharmacy
Figure 20. Global Ophthalmic Drugs Market: Pharmacy (2019-2024) & (K MT)
Figure 21. Global Ophthalmic Drugs Sales Market Share by Application (2023)
Figure 22. Global Ophthalmic Drugs Revenue Market Share by Application in 2023
Figure 23. Ophthalmic Drugs Sales Market by Company in 2023 (K MT)
Figure 24. Global Ophthalmic Drugs Sales Market Share by Company in 2023
Figure 25. Ophthalmic Drugs Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Ophthalmic Drugs Revenue Market Share by Company in 2023
Figure 27. Global Ophthalmic Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Ophthalmic Drugs Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Ophthalmic Drugs Sales 2019-2024 (K MT)
Figure 30. Americas Ophthalmic Drugs Revenue 2019-2024 ($ Millions)
Figure 31. APAC Ophthalmic Drugs Sales 2019-2024 (K MT)
Figure 32. APAC Ophthalmic Drugs Revenue 2019-2024 ($ Millions)
Figure 33. Europe Ophthalmic Drugs Sales 2019-2024 (K MT)
Figure 34. Europe Ophthalmic Drugs Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Ophthalmic Drugs Sales 2019-2024 (K MT)
Figure 36. Middle East & Africa Ophthalmic Drugs Revenue 2019-2024 ($ Millions)
Figure 37. Americas Ophthalmic Drugs Sales Market Share by Country in 2023
Figure 38. Americas Ophthalmic Drugs Revenue Market Share by Country in 2023
Figure 39. Americas Ophthalmic Drugs Sales Market Share by Type (2019-2024)
Figure 40. Americas Ophthalmic Drugs Sales Market Share by Application (2019-2024)
Figure 41. United States Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Ophthalmic Drugs Sales Market Share by Region in 2023
Figure 46. APAC Ophthalmic Drugs Revenue Market Share by Regions in 2023
Figure 47. APAC Ophthalmic Drugs Sales Market Share by Type (2019-2024)
Figure 48. APAC Ophthalmic Drugs Sales Market Share by Application (2019-2024)
Figure 49. China Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Ophthalmic Drugs Sales Market Share by Country in 2023
Figure 57. Europe Ophthalmic Drugs Revenue Market Share by Country in 2023
Figure 58. Europe Ophthalmic Drugs Sales Market Share by Type (2019-2024)
Figure 59. Europe Ophthalmic Drugs Sales Market Share by Application (2019-2024)
Figure 60. Germany Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Ophthalmic Drugs Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Ophthalmic Drugs Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Ophthalmic Drugs Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Ophthalmic Drugs Sales Market Share by Application (2019-2024)
Figure 69. Egypt Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Ophthalmic Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Ophthalmic Drugs in 2023
Figure 75. Manufacturing Process Analysis of Ophthalmic Drugs
Figure 76. Industry Chain Structure of Ophthalmic Drugs
Figure 77. Channels of Distribution
Figure 78. Global Ophthalmic Drugs Sales Market Forecast by Region (2025-2030)
Figure 79. Global Ophthalmic Drugs Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Ophthalmic Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Ophthalmic Drugs Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Ophthalmic Drugs Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Ophthalmic Drugs Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Alkaline Phosphatase Kits Market Growth 2023-2029
US$ 3,660.00
March 2023
107 pages
Global Ostomy Products for Temporary Ostomies Market Growth 2024-2030
US$ 3,660.00
December 2024
143 pages
Global Hemostasis Valve Connectors Market Growth 2023-2029
US$ 3,660.00
February 2023
108 pages
Global Epileptic Alarm Market Growth 2024-2030
US$ 3,660.00
November 2024
92 pages
Global Parkinson's Disease (PD) Drugs Market Growth 2025-2031
US$ 3,660.00
October 2025
144 pages
